A randomized, double-blind, placebo-controlled, crossover study to evaluate the human abuse liability of solriamfetol, a selective dopamine and norepinephrine reuptake inhibitor
Titel:
A randomized, double-blind, placebo-controlled, crossover study to evaluate the human abuse liability of solriamfetol, a selective dopamine and norepinephrine reuptake inhibitor
Auteur:
Carter, Lawrence P Henningfield, Jack E Wang, Y Grace Lu, Yuan Kelsh, Debra Vince, Bradley Sellers, Edward